Aeterna Zentaris completes key phase of DETECT trial By Investing.com
Aeterna Zentaris Inc. (NASDAQ:), a biopharmaceutical company specializing in endocrine-related therapeutics and diagnostics, today announced the completion of the final ...
Aeterna Zentaris Inc. (NASDAQ:), a biopharmaceutical company specializing in endocrine-related therapeutics and diagnostics, today announced the completion of the final ...